Press release
Global Liquid Biopsy Market is poised to witness a healthy CAGR of 17% by 2026 - Growing Occurrence of Cancer across the world & Increasing Preference for Non-Invasive Therapies
Advent of Medical Technologies for Liquid Biopsy Drives the Global Liquid Biopsy Market
Liquid biopsy is an emerging healthcare technology and has the potential to revolutionize early cancer detection by analyzing available ctDNA for specific mutation profiles, fragmentation patterns, and methylation signatures. The rapid developments in a digital polymerase chain reaction (PCR) and next-generation sequencing (NGS) technologies has led to a significant reduction in sequencing costs with the improvement in the accuracy of liquid biopsy. Further medical innovations in technology is expected to trigger the growth of the liquid biopsy market in the upcoming years.
Adoption of Circulating Biomarkers for Early Detection and Screening of Cancer
Currently, circulating cell-free DNA (cfDNA) and circulating tumor cells (CTCs) are the commonly used liquid biopsy-derived biomarkers. In the recent years, CTCs have gained a significant importance in detecting tumors, replacing invasive tissue biopsies not only due to their ease in sampling but also in providing data regarding tumor conditions in a 'real-time' manner. CTCs can also be used in vivo for the generation of patient-derived tumor models which assist in cancer treatments.
"Liquid Biopsy is a dynamic and consistently emerging segment. Technological advancements directed towards faster and more convenient diagnosis will drive the growtrhy of the global market. Liquid biopsies could be a game-changer in cancer testing." - Head of Diagnostic Biomarkers, Liquid Biopsy Company, United States
Upcoming Market Challenges: Liquid Biopsy Market
Some of the primary challenges restricting the growth of the liquid biopsy market are stringent government regulations, suboptimal patient adherence, low sensitivity for early-stage diseases, and high false-positive rates. The wrong diagnosis can lead to false-negative results which can impact the informative value of the liquid biopsy tests for cancer.
Geographic Overview: North America Leads the Adoption of Liquid Biopsy Market
From a regional perspective, North America holds the largest share of the liquid biopsy market. The growing prevalence of cancer cases among the US population, rising adoption of liquid biopsy for the diagnosis of cancer, higher patient preference for non-invasive diagnosis and monitoring and the presence of established players in this region are some of the key factors driving the market growth.
Competitive Landscape Analysis: Liquid Biopsy Market
Some of the established and emerging players operating in the global liquid biopsy market are F. Hoffmann-La Roche Ltd., Myriad Genetics Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., Guardant Health Inc., MDxHealth SA, and Illumina Inc., among others.
Growing Interest of Private Equity Firms in the Liquid Biopsy Market
To leverage upcoming growth opportunities in the liquid biopsy market, private equity firms are making significant investments in potentially high-growth areas/companies in this market.
For instance, In May 2022, BioMarks Diagnostics secured $1.5 million from a private financing round to accelerate the commercialization of its liquid biopsy technology.
Explore Detailed Insights on Liquid Biopsy Market with TOC & Sample Report @ https://meditechinsights.com/liquid-biopsy-market/
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Liquid Biopsy Market is poised to witness a healthy CAGR of 17% by 2026 - Growing Occurrence of Cancer across the world & Increasing Preference for Non-Invasive Therapies here
News-ID: 2740792 • Views: …
More Releases from Medi-Tech Insights
Sterilization Equipment Market Shows Strong Investment Potential with 7-9% CAGR …
The global sterilization equipment market is set to experience significant growth, with an expected CAGR of 7-9% over the next 5 years. This growth is driven by increasing demand for sterilization in healthcare facilities, stringent infection control regulations, rising surgical procedures, necessity to curb hospital-acquired infections (HAIs), and advancements in sterilization technologies.
Sterilization equipment plays a critical role in ensuring the safety and hygiene of medical instruments, devices, and environments. These…
Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tec …
The global biologics market is set to witness a growth rate of 10-12% in the next 5 years. Rising prevalence of chronic diseases; continued advancements in biotechnology; growing investment in biopharmaceutical R&D; and growing strategic partnerships between biotech firms & larger pharmaceutical companies are some of the key factors driving the biologics market.
Biologics are a class of medications derived from living organisms, including proteins, sugars, and nucleic acids among others.…
Telemedicine Market to Grow at 16-18% CAGR By 2029, Fueled by Tech Advancements …
The global telemedicine market is set to witness a robust growth rate of 16-18% over the next five years. This growth is driven by the increasing adoption of digital healthcare solutions, a rise in chronic disease prevalence, an aging population demanding more accessible care, technological advancements in telehealth platforms, growing government support, and the shift toward remote patient monitoring and virtual care solutions.
Telemedicine refers to the remote diagnosis, treatment, and…
High Flow Oxygen Therapy Market Set to Grow at 7% CAGR by 2029 Driven by Rising …
The high flow oxygen therapy (HFOT) market is growing at a projected compound annual growth rate (CAGR) of around 7% in the forecast period. Key drivers include the rising prevalence of respiratory diseases such as COPD, pneumonia, and acute respiratory failure, along with increased adoption of non-invasive treatments. Technological advancements in HFOT devices and the growing elderly population further support market growth. However, high device costs and limited reimbursement in…
More Releases for Liquid
Vitamins: The Liquid Goldmine in the Booming Liquid Dietary Supplements Market
The liquid dietary supplements market is experiencing a surge in popularity, driven by consumers seeking convenient and effective ways to boost their health and wellness. Among the diverse offerings, the vitamins segment stands out as a high-opportunity area, catering to a wide range of health needs and preferences.
Market Dynamics and Growth Drivers
Liquid vitamins offer a compelling alternative to traditional pills and capsules, providing faster absorption, easier consumption, and customizable dosages.…
Thermoelectric Assemblies Market, By Type (Air to Air, Direct to Air, Liquid to …
The thermoelectric assemblies market is expected to witness market growth at a rate of 8.25% in the forecast period of 2021 to 2028. Data Bridge Market Research report on thermoelectric assemblies market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the application of thermoelectric assemblies in the food and beverage industry…
Southeast Asia Liquid Gases Market : Growing with a CAGR of 7.1%, By Type (Liqui …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Southeast Asia Liquid Gases Market growing with a CAGR of 7.1%, By Type (Liquid …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Southeast Asia liquid gases market growing with a CAGR of 7.1%, Size, Share, Tre …
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged products…
Dual Chamber Prefilled Syringes Market 2021 by Product (Liquid/Powder, Liquid/Li …
The Dual Chamber Prefilled Syringes Market report examines the market size by vital countries/regions, product type, application, historical data, and estimate to forecast. It helps to understand the structure of the Dual Chamber Prefilled Syringes Market by recognizing its different sub-segments. Furthermore, the report focuses on key market players to determine, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next few…
